EFFECT OF LINAGLIPTIN ON CARDIOVASCULAR AND KIDNEY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE: CARMELINA®
AACE ePoster Library. Toto R. 04/25/19; 262467; 591056
Robert Toto
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}